Morgan Lewis partner Dennis Gucciardo spoke with MedTech Dive for an article about the COVID-19 pandemic’s impact on the US Food and Drug Administration’s enforcement efforts. In the piece, he discussed the potential for virtual inspections. “I just don't see the time or place where a manufacturing representative is going to put on a Zoom call and go walk around the manufacturing space, said Dennis. “I just don't see that as a realistic possibility."